This is a promotional website fully funded and created by SERB Pharmaceuticals for UK Healthcare Professionals only.
If you are a member of public please click here

Report Adverse Event Here | Prescribing Information | Summary of Product Characteristics

For full safety profile, please consult the SmPC

Contraindications

CONTRAINDICATIONS1

  • Hypersensitivity to the active substance or to any of the excipients
  • Decompensated cardiac diseases (e.g. acute myocardial infarction, acute mycoarditis, acute pancarditis)
  • Untreated adrenal insufficiency
  • Untreated hyperthyroidism
  • Untreated pituitary insufficiency (when leading to adrenal insufficiency requiring treatment)
  • Combination of levothyroxine with an antithyroid agent for hyperthyroidism is not indicated during pregnancy

Special warnings and precautions for use1

Before starting a thyroid hormone therapy, the following diseases or conditions should be excluded or treated:
  • Coronary heart disease
  • Angina pectoris
  • Hypertension
  • Pituitary and/or adrenal insufficiency
  • Thyroid autonomy
Click here for SmPC further information regarding patients with cardiovascular disorders, adrenal insufficiency, diabetes, epilepsy, osteoporosis, low weight neonates and information on hypersensitivity reactions associated with Levothyroxine SERB.
References:
  1. Levothyroxine SERB 200 mcg/ml solution for injection/infusion Summary of Product Characteristics (SmPC)